Stem Cells vs. the FDA: Innovation, Enforcement & the Future of Regenerative Medicine

Journalists covering regenerative medicine, FDA enforcement, biotech policy, or patient safety: this episode is built for your beat.

On The Ultimate Assist, John Stockton and Ken Ruettgers sit down with Dr. Harry Adelson (Dosere Clinics) and Dr. Chuck Meeker (PhD scientist + patent attorney) to unpack what’s really happening inside the stem cell and birth-tissue conversation—clinically, legally, and culturally. We explore bone marrow vs. birth tissue, the innovation-vs.-regulation collision, how FDA language restrictions shape what clinics can say, and the real-world outcomes that keep patients looking for alternatives to surgery. We also address medical tourism, hype vs. evidence, and the public health ripple effects that keep this industry under a microscope.

If you’re producing a story, building a segment, or looking for expert commentary, this is a strong starting point.

👉 Want your question featured (or need a quick quote/source)? Email us and join the conversation.